We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+4.68%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$774M
AUM Growth
+$32M
Cap. Flow
+$4.48M
Cap. Flow %
0.58%
Top 10 Hldgs %
60.49%
Holding
103
New
9
Increased
21
Reduced
5
Closed
13

Top Buys

Rank Stock Value
1
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
+$3.41M
2
AMGN icon
Amgen
AMGN
+$2.71M
3
POT
Potash Corp Of Saskatchewan
POT
+$1.87M
4
DVA icon
DaVita
DVA
+$1.41M
5
ESRX
Express Scripts Holding Company
ESRX
+$1.36M

Top Sells

Rank Stock Value
1
SRCL
Stericycle Inc
SRCL
+$6.93M
2
DO
Diamond Offshore Drilling
DO
+$5.46M
3
BA icon
Boeing
BA
+$2.7M
4
CBI
Chicago Bridge & Iron Nv
CBI
+$1.98M
5
OPK icon
Opko Health
OPK
+$917K

Sector Composition

Rank Sector Weight
1 Financials 39.59%
2 Healthcare 25.46%
3 Technology 10.29%
4 Industrials 10.13%
5 Energy 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JKHY icon
51
Jack Henry & Associates
JKHY
$10.9B
$1.41M 0.18%
13,700
– –
UTHR icon
52
United Therapeutics
UTHR
$22.1B
$1.35M 0.17%
11,490
– –
AMAG
53
DELISTED
AMAG Pharmaceuticals
AMAG
$1.29M 0.17%
70,000
– –
BUD icon
54
AB InBev
BUD
$159B
$1.21M 0.16%
10,100
– –
SRPT icon
55
Sarepta Therapeutics
SRPT
$1.92B
$1.13M 0.15%
+25,000
New +$999K
AKTX
56
Akari Therapeutics
AKTX
$13.5M
$929K 0.12%
189
+114
+152% +$427K
STOR
57
DELISTED
STORE Capital Corporation
STOR
$913K 0.12%
+36,700
New +$893K
ALDX icon
58
Aldeyra Therapeutics
ALDX
$91.1M
$777K 0.1%
107,858
– –
OCRX
59
DELISTED
Ocera Therapeutics, Inc.
OCRX
$771K 0.1%
676,596
+300,000
+80% +$322K
DNOW icon
60
DNOW Inc
DNOW
$3.01B
$769K 0.1%
55,675
– –
ADMS
61
DELISTED
Adamas Pharmaceuticals
ADMS
$635K 0.08%
+30,000
New +$550K
BIVV
62
DELISTED
Bioverativ Inc. Common Stock
BIVV
$628K 0.08%
11,000
– –
SYNT
63
DELISTED
Syntel Inc
SYNT
$614K 0.08%
31,270
– –
VWO icon
64
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$479K 0.06%
11,000
– –
AKAO
65
DELISTED
Achaogen Inc
AKAO
$479K 0.06%
+30,000
New +$571K
L icon
66
Loews
L
$23.1B
$464K 0.06%
9,700
– –
CYOU
67
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$291K 0.04%
7,340
– –
SGI
68
Somnigroup International
SGI
$13.7B
$281K 0.04%
17,400
– –
BIDU icon
69
Baidu
BIDU
$35.9B
$277K 0.04%
1,120
– –
ECL icon
70
Ecolab
ECL
$79.8B
$270K 0.03%
2,100
– –
NVR icon
71
NVR
NVR
$17.1B
$257K 0.03%
90
– –
CPRI icon
72
Capri Holdings
CPRI
$1.77B
$252K 0.03%
+5,260
New +$214K
CI icon
73
Cigna
CI
$72.4B
$241K 0.03%
1,290
– –
RTN
74
DELISTED
Raytheon Company
RTN
$241K 0.03%
1,290
– –
VRSN icon
75
VeriSign
VRSN
$26B
$237K 0.03%
2,230
– –
1 2
3
4 5

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q3 2017 Portfolio in Review

As of Q3 2017, Hikari Power held 103 positions worth $774M, up 4.3% from $741M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Hikari Power's Q3 2017 filing shows 9 new, 21 increased, 5 reduced and 13 closed positions. Its largest new stake was Progenics Pharmaceuticals Inc: 200,000 shares worth $1.47M. The largest sale was Stericycle Inc, an estimated $6.93M.

By sector, the portfolio is most concentrated in Financials at 40% of assets, up from 39% a quarter earlier, followed by Healthcare and Technology.

  • Hikari Power's largest Q3 2017 buy was Progenics Pharmaceuticals Inc: 200,000 shares worth $1.47M.
  • Hikari Power added most to Synergy Pharmaceuticals, Inc Common Stock in Q3 2017, an estimated $3.41M increase.
  • Hikari Power's biggest Q3 2017 reduction was Stericycle Inc, cutting an estimated $6.93M.
  • Hikari Power fully exited Opko Health in Q3 2017, selling an estimated $917K.
  • Hikari Power's ten largest holdings make up 60% of its $774M portfolio in Q3 2017.
  • Hikari Power opened 9 new positions and closed 13 in Q3 2017.
  • Hikari Power's portfolio value rose 4.3% quarter-over-quarter to $774M.

Based on Hikari Power's 13F filing for Q3 2017, filed 8 Nov 2017.